AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Yin, LH Fu, SQ Wang, XH Nanakorn, T Won, J Deisseroth, A
Citation: Lh. Yin et al., Sensitization of prostate cancer cell lines to 5-fluorocytosine induced byadenoviral vector carrying a CD transcription unit, CHIN MED J, 114(9), 2001, pp. 972-975

Authors: Peng, XY Won, JH Rutherford, T Fujii, T Zelterman, D Pizzorno, G Sapi, E Leavitt, J Kacinski, B Crystal, R Schwartz, P Deisseroth, A
Citation: Xy. Peng et al., The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines, CANCER RES, 61(11), 2001, pp. 4405-4413

Authors: Mota, A Deisseroth, A
Citation: A. Mota et A. Deisseroth, Systemic treatment of malignant melanoma, CLIN PLAST, 27(3), 2000, pp. 463

Authors: Shrimdkandada, S Fu, SQ Yin, LH Guo, XYD Nanakorn, T Pang, XY Dizon, D Lin, D Cooperberg, M Won, JH Deisseroth, A
Citation: S. Shrimdkandada et al., Methods for chemoprotection and chemosensitization - MDR-1 for chemoprotection using retroviruses to modify hematopoietic cells and cytosine deaminase for chemosensitization using adenoviral vectors to modify epithelian neoplastic cells, METH MOL M, 35, 2000, pp. 609-616

Authors: Burtness, BA Psyrri, A Rose, M D'Andrea, E Staugaard-Hahn, C Henderson-Bakas, M Clark, MB Mechanic, S Krause, D Snyder, E Cooper, RB Abrantes, J Corringham, R Deisseroth, A Cooper, DL
Citation: Ba. Burtness et al., A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells, BONE MAR TR, 23(4), 1999, pp. 311-315

Authors: Nanakorn, T Fu, SQ Yin, LH Rahman, Z Kavanagh, J Fugii, T Chung, IJ Yap, R Giles, R Pizzorno, G Deisseroth, A
Citation: T. Nanakorn et al., Genetic therapy of solid tumor and hematopoietic neoplasms, PROG ANTI C, 2, 1999, pp. 96-105
Risultati: 1-6 |